Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2018; 18(2):92-95
DOI: 10.5428/pcar20180203
Study on the life quality of children with attention deficit hyperactivity disorder treated with atomoxetine hydrochloride
1. ZHAO JingJing(Department of Pediatrics,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China Gsldrhs@sina.com)
2. XU Tong(Department of Pediatrics,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China tongxub@aliyun.com)
3. ZHOU Yi(Department of Pediatrics,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China )
4. SHUAI RuiXue(Department of Pediatrics,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China )
5. ZHANG CaiYing(Department of Pediatrics,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China )
6. WANG DeFeng(Department of Pediatrics,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China )
ABSTRACT  Objective: To observe the efficacy of atomoxetine hydrochloride on the life quality of children with attention deficit hyperactivity disorder (ADHD).Methods: From September 2016 to September 2017,62 children diagnosed as ADHD were enrolled who sought medical care in ADHD clinic of Department of Pediatrics,Changzheng Hospital,Second Military Medical University.Thirty-two patients were treated with atomoxetine hydrochloride for 6 months(the treatment group),30 patients without medication were enrolled as the control group.SNAP-Ⅳ scale and CHIP-CE scale were used to evaluate the indexes of symptoms and life quality,respectively.Questionnaire survey and evaluations were made before treatment (at baseline),2 months and 6 months after treatment,respectively.Results: Before treatment,the basic information,SNAP-Ⅳ scores and CHIP-CE scores in the two groups had no statistical differences(P>0.05).After treatment with atomoxetine hydrochloride,the SNAP-Ⅳ scores of children in the treatment group significantly decreased,and CHIP-CE scores significantly increased compared with the control group(P<0.01).Conclusion: Atomoxetine hydrochloride could significantly improve the symptoms and life quality of children with ADHD.
Welcome to PCAR! You are the number 357 reader of this article!
Please cite this article as:
ZHAO JingJing,XU Tong,ZHOU Yi,SHUAI RuiXue,ZHANG CaiYing,WANG DeFeng,. Study on the life quality of children with attention deficit hyperactivity disorder treated with atomoxetine hydrochloride[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(2): 92-95.
References:
1. Peasgood T,Bhardwaj A,Biggs K,et al.The impact of ADHD on the health and well-being of ADHD children and their siblings[J].Eur Child Adolesc Psychiatry,2016,25(11):1217-1231.
2. Hutchison S L,Ghuman J K,Ghuman H S,et al.Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults:a review[J].Ther Adv Psychopharmacol,2016,6(5):317-334.
3. Harvey E A,Breaux R P,Lugo-Candelas C I.Early development of comorbidity between symptoms of attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD)[J].J Abnorm Psychol,2016,125(2):154-167.
4. Montoya A,Quail D,Anand E,et al.Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder,based on a pooled analysis[J].Atten Defic Hyperact Disord,2014,6(1):25-34.
5. Banaschewski T,Johnson M,Lecendreux M,et al.Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder[J].CNS Drugs,2014,28(12):1191-1203.
6. Wang L J,Chen C K,Huang Y S.Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate[J].J Child Adolesc Psychopharmacol,2015,25(3):246-253.
7. Galloway H,Newman E.Is there a difference between child self-ratings and parent proxy-ratings of the quality of life of children with a diagnosis of attention-deficit hyperactivity disorder (ADHD)? A systematic review of the literature[J].Atten Defic Hyperact Disord,2017,9(1):11-29.
8. Jonsson U,Alaie I,Lfgren Wilteus A,et al.Annual research review: quality of life and childhood mental and behavioural disorders-a critical review of the research[J].J Child Psychol Psychiatry,2017,58(4):439-469.
9. Coghill D R,Banaschewski T,Soutullo C,et al.Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder[J].Eur Child Adolesc Psychiatry,2017,26(11):1283-1307.
10. Marques J C,Oliveira J A,Goulardins J B,et al.Comparison of child self-reports and parent proxy-reports on quality of life of children with attention deficit hyperactivity disorder[J].Health Qual Life Outcomes,2013,11(1):186.
11. Coghill D,Hodgkins P.Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls[J].Eur Child Adolesc Psychiatry,2016,25(3):261-271.
12. ZHANG YueBing,LI RongQin,WANG AiQin,et al.Quality of life and related factors in children with attention deficit hyperactivity disorder[J].Chin J Child Health Care,2016,24(8):804-806,813.In Chinese with English abstract.
13. YU Guo,LI GuoFu,Markowitz J S.Atomoxetine:a review of its pharmacokinetics and pharmacogenomics relative to drug disposition[J].J Child Adolesc Psychopharmacol,2016,26(4):314-326.
14. Hutchison S L,Ghuman J K,Ghuman H S,et al.Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children,adolescents and adults:a review[J].Ther Adv Psychopharmacol,2016,6(5):317-334.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口